Enhancement Kinetics
Enhancement kinetics describe the temporal behavior of contrast uptake and washout in a breast MRI finding. Kinetics are assessed from the dynamic contrast enhanced (DCE) series and provide supplemental information to morphologic assessment.
Role of Kinetics
Kinetics are supplemental — they should be assessed when morphology is not definitively benign or suspicious. Morphology (shape, margin, internal enhancement pattern) remains the primary assessment tool.
Two Phases
1. Early Phase (First 60–120 Seconds After Contrast)
Describes the rate of initial contrast uptake:
| Category | Description | Significance |
|---|---|---|
| Slow | Gradual initial enhancement | More benign-favoring |
| Medium | Intermediate rate | Nonspecific |
| Fast | Rapid initial enhancement | More suspicious |
Breast cancers characteristically enhance rapidly in the early phase due to abnormal, highly permeable neovascularity.
2. Delayed Phase (After Initial Enhancement)
Describes the behavior of enhancement after the early peak:
| Category | Description | Significance |
|---|---|---|
| Persistent | Signal continues to increase over time | More benign-favoring |
| Plateau | Signal stabilizes (flat) | Intermediate |
| Washout | Signal decreases after initial peak | Most suspicious |
Board Pearl
Washout kinetics (delayed phase signal decreases after initial enhancement) is the most suspicious kinetic pattern and correlates with malignancy. It reflects rapid contrast ingress and egress characteristic of tumor neovascularity.
Persistent kinetics (signal continues to rise) is the most benign-favoring pattern — most fibroadenomas show persistent enhancement.
Kinetics in Practice
- Most commonly used to help characterize findings where morphology alone is indeterminate
- Not required for findings that are morphologically definitively benign or clearly suspicious
- Computer-aided evaluation (CAE/CAD) software can quantitatively map kinetic curves across the breast
Ultrafast Protocols
Newer ultrafast/fast protocols acquire multiple early post-contrast series, allowing analysis of:
- Time-to-enhancement — how quickly a lesion enhances relative to BPE
- Slope of the contrast uptake curve
- Area under the signal intensity-time curve
- Enhancement that occurs before background parenchymal enhancement (a suspicious sign)
Limitations
- Kinetics depend on contrast dose, injection rate, timing of sequences, and patient-specific factors
- Washout can occasionally occur in benign entities (e.g., some fibroadenomas)
- Persistent enhancement does not exclude malignancy